Better Choices, Better Health is the new online version of Stanford University's Chronic Disease Self Management Program (CDSMP). This six-week, interactive workshop is designed for people with a range of chronic health conditions, including diabetes. It is free for people in seven pilot states, thanks to a grant from The Atlantic Philanthropies.
NaturEra, (http://www.NaturEra.com) a dietary supplements emerging leader, this month announced the launch of its new Sugar Crush dietary supplements would take place at the American Association of Diabetes Educators meeting in San Antonio, Texas. Sugar Crush research has been accepted for Poster presentation at the AADE meeting. The full clinical research study (http://www.naturera.com/Manuscript.pdf) shows that NaturEra's 'Sugar Crush' and 'Sugar Crush Daily' dietary supplement formulas used in combination lower and maintain healthy blood sugar levels for people with diabetes.
In a recent study of the relationship between vitamin D deficiency and glucose intolerance in people with type 2 diabetes, more than 90 percent of the type 2 diabetes patients were found to be deficient in vitamin D, with their control over the disease worsening as their deficiency increased.
We continue to monitor the progress of studies to determine the effectiveness of salsalate, a generic aspirin-like drug, to reduce inflammation and lower blood glucose in people with type 2 diabetes. As previously reported here in October 2008 and January 2009, researchers from the Joslin Diabetes Center at Harvard University are conducting clinical trials to determine if this well known and proven drug for joint pain can be added to the list of diabetes drugs. Recently, results from a three-month trial were announced online in the Annals of Internal Medicine, showing that those who took salsalate demonstrated significantly improved blood glucose levels.
Tests of an experimental drug called CPSI-1306 at Ohio State University were so successful at lowering inflammation and blood sugar levels in lab mice with type 2 diabetes that scientists consider it a prime candidate to become a new therapy for the disease.
A controversial New York doctor is poised to begin surgical trials on non-obese diabetes patients in an attempt to reverse their disease with gastric bypass surgery. Dr. Francesco Rubino, the chief of gastrointestinal surgery at New York-Presbyterian/Weill Cornell Medical Center, believes that because gastric surgery has been shown to be highly effective in remitting diabetes symptoms, the procedure should now be allowed among non-overweight type 2s.
I have always felt that a little snooze in the middle of the afternoon works better for me than a jolt of caffeine. However, the guilt induced by the very thought of sleeping during the day (especially at work) has kept me drinking coffee or tea instead of crashing on my desk and drooling on my keyboard.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.